Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC14114LIXILAN JP-O2NCT02752828Publication's Reference
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC14943Lixilan-O-APNCT03798054Publication's Reference
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
EFC14944Lixilan-L-CNNCT03798080Publication's Reference
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
INSLIL08556LixiLan-IndiaNCT03529123Summary
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
LPS14860LixiLan-DNCT03434119Tabulated Results
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
LPS15017Global Premix2017-003370-13Tabulated Results
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
LPS15544LixilanOne CANNCT03767543Summary
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
LPS16664NAEudraCT Number: 2019-004080-43Tabulated results
INSULIN GLARGINE /LIXISENATIDE
Soliqua
Diabetes Mellitus, Type 2
PDY14115NANCT02713477Publication's Reference
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
EFC11628EDITION INCT01499082Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted